Big Pharma Pushes Trump to Ease Medicare Drug Prices

Published on November 27, 2024

The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest prescription drugs once president-elect Donald Trump is back in office, according to lobbyists, executives, analysts and healthcare policy…

Read Full Article (External Site)